tiprankstipranks
Advertisement

EFAX - ETF AI Analysis

Compare

Top Page

EFAX

SPDR MSCI EAFE Fossil Fuel Free ETF (EFAX)

Rating:66Neutral
Price Target:
EFAX, the SPDR MSCI EAFE Fossil Fuel Free ETF, has a solid overall rating driven mainly by high-quality global leaders like AstraZeneca, Novartis, HSBC, Toyota, and ASML, which show strong financial performance, positive earnings outlooks, and generally supportive technical and valuation profiles. This strength is slightly offset by holdings such as Commonwealth Bank of Australia and some financial names that face issues like high leverage, cash flow challenges, or bearish momentum, and the fund’s meaningful exposure to large financial institutions adds sector risk that can weigh on its rating during banking or credit downturns.
Positive Factors
Broad International Diversification
The fund spreads its investments across many developed markets like Japan, the UK, and several European countries, which helps reduce reliance on any single economy.
Solid Recent Performance
The ETF has shown steady gains over the past month, three months, and year-to-date, indicating generally supportive market conditions for its holdings.
Reasonable Expense Ratio
The fund’s expense ratio is relatively low for a specialized international strategy, allowing investors to keep more of their returns over time.
Negative Factors
Heavy Tilt to Financials and Industrials
A large share of the portfolio is in financial and industrial companies, which can increase sensitivity to economic cycles and sector-specific downturns.
Mixed Performance Among Top Holdings
While some leading positions like ASML and Mitsubishi UFJ have performed strongly, others such as AstraZeneca, Nestlé, and SAP have been weaker, which can dampen overall returns.
Limited U.S. Exposure
The ETF has only a small allocation to U.S. stocks, so investors relying on it alone may miss out on potential gains from the U.S. market and should consider how it fits with their broader portfolio.

EFAX vs. SPDR S&P 500 ETF (SPY)

EFAX Summary

EFAX is the SPDR MSCI EAFE Fossil Fuel Free ETF, which tracks the MSCI EAFE ex Fossil Fuels Index. It invests in large and mid-sized companies in developed markets outside North America, mainly in countries like Japan, the UK, and France. The fund holds well-known names such as Nestlé, Toyota, and ASML. It avoids companies involved in extracting or producing fossil fuels, appealing to investors who want broad international diversification while supporting environmental goals. A key risk is that its value can rise or fall with global stock markets and may lag funds that include traditional energy companies.
How much will it cost me?The SPDR MSCI EAFE Fossil Fuel Free ETF (EFAX) has an expense ratio of 0.20%, which means you’ll pay $2 per year for every $1,000 invested. This is lower than average for actively managed funds but slightly higher than many passively managed ETFs because it tracks a specialized index focused on sustainability.
What would affect this ETF?The EFAX ETF could benefit from increasing global demand for sustainable investments and the growth of developed markets outside North America, particularly in sectors like financials and technology, which have significant weight in the fund. However, challenges such as economic slowdowns in Europe or Asia, regulatory changes affecting key industries, or currency fluctuations in non-North American markets could negatively impact performance. Additionally, its exclusion of fossil fuel companies may limit exposure to potential gains in the energy sector during periods of high oil prices.

EFAX Top 10 Holdings

EFAX leans heavily on overseas financials and health care, with names like HSBC and Mitsubishi UFJ acting as steady, if unspectacular, anchors. The real spark has come from ASML, whose rising longer-term trend has helped pull the fund forward despite some recent wobbling. Big pharma is more of a mixed bag: Novartis is quietly supporting returns, while Roche and AstraZeneca have been losing a bit of steam. Consumer giant Nestlé and Japan’s Toyota are also lagging, reminding investors that this fossil-fuel-free, developed-markets ex-North America fund isn’t immune to global slowdowns.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding NV2.83%$13.00M€443.48B109.20%
76
Outperform
AstraZeneca1.55%$7.13M$313.97B52.31%
80
Outperform
Novartis AG1.55%$7.13MCHF224.91B41.41%
80
Outperform
Roche Holding AG1.50%$6.89M$318.20B40.41%
73
Outperform
HSBC Holdings1.49%$6.84M£218.71B72.51%
80
Outperform
Nestlé SA1.34%$6.16MCHF198.22B1.99%
71
Outperform
Toyota Motor1.09%$5.01M¥42.32T43.92%
80
Outperform
Commonwealth Bank of Australia1.09%$4.99MAU$288.89B19.66%
64
Neutral
Mitsubishi UFJ Financial Group1.03%$4.75M¥31.22T60.04%
76
Outperform
Siemens1.00%$4.58M€162.63B18.22%
74
Outperform

EFAX Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price
Price Trends
50DMA
51.98
Negative
100DMA
51.02
Negative
200DMA
49.25
Positive
Market Momentum
MACD
-0.61
Negative
RSI
50.36
Neutral
STOCH
84.34
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For EFAX, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 49.81, equal to the 50-day MA of 51.98, and equal to the 200-day MA of 49.25, indicating a neutral trend. The MACD of -0.61 indicates Negative momentum. The RSI at 50.36 is Neutral, neither overbought nor oversold. The STOCH value of 84.34 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for EFAX.

EFAX Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$476.19M0.20%
66
Neutral
$818.21M0.12%
65
Neutral
$698.83M0.42%
67
Neutral
$653.06M0.48%
64
Neutral
$641.41M0.27%
64
Neutral
$353.54M0.37%
59
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
EFAX
SPDR MSCI EAFE Fossil Fuel Free ETF
50.51
10.29
25.58%
DMXF
iShares ESG Advanced MSCI EAFE ETF
IQDG
WisdomTree International Quality Dividend Growth Fund
DWM
WisdomTree International Equity Fund
NUDM
Nuveen ESG International Developed Markets Equity ETF
JPIN
J.P. Morgan Diversified Return International Equity ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement